Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: MIKE DUBIS who wrote (444)	1/8/1998 1:02:00 AM
From: BigKNY3	Respond to of 9523

Mike: Here are some facts: -Since Viagra has been given priority review, the FDA has until 3/29/98 to inform PFE of the status of the NDA submission. -To date, every completed priority reviewed NDA has been approved by the FDA. -In next week's Business Week, the PFE CEO will be interviewed. He says that Viagra "could be approved by the first quarter". Given that we are dealing with the FDA, this is a very positive statement. No one, including anyone at the FDA, knows the exact date that Viagra will be approved. businessweek.com Have PFun! BigKNY3